Retour
42
Fourchette du Jour
4,00 €
4,28 €
Fourchette 52 Semaines
4,00 €
4,28 €
Volume
612
Moyenne 50J / 200J
4,00 €
/
4,00 €
Clôture Précédente
4,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 15,2 | 0,4 |
| P/B | 0,3 | 2,9 |
| ROE % | 1,9 | 3,7 |
| Net Margin % | 6,1 | 3,8 |
| Rev Growth 5Y % | 19,9 | 10,0 |
| D/E | 0,1 | 0,2 |
Points Clés
Revenue grew 19,93% annually over 5 years — strong growth
Earnings declined -79,99% over the past year
ROE of 1,94% is below average
Debt/Equity of 0,13 — conservative balance sheet
Generating 740,45M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 30,51%
Croissance
Revenue Growth (5Y)
19,93%
Revenue (1Y)-10,58%
Earnings (1Y)-79,99%
FCF Growth (3Y)-9,74%
Qualité
Return on Equity
1,94%
ROIC2,14%
Net Margin6,14%
Op. Margin10,06%
Sécurité
Debt / Equity
0,13
Current Ratio1,72
Interest Coverage4,70
Valorisation
P/E Ratio
15,21
P/B Ratio0,30
EV/EBITDA10,15
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10,58% | Revenue Growth (3Y) | -3,46% |
| Earnings Growth (1Y) | -79,99% | Earnings Growth (3Y) | -55,07% |
| Revenue Growth (5Y) | 19,93% | Earnings Growth (5Y) | -30,63% |
| Profitability | |||
| Revenue (TTM) | 6,60B | Net Income (TTM) | 405,14M |
| ROE | 1,94% | ROA | 1,41% |
| Gross Margin | 33,95% | Operating Margin | 10,06% |
| Net Margin | 6,14% | Free Cash Flow (TTM) | 740,45M |
| ROIC | 2,14% | FCF Growth (3Y) | -9,74% |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 1,72 |
| Interest Coverage | 4,70 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 15,21 | P/B Ratio | 0,30 |
| P/S Ratio | 0,93 | PEG Ratio | -0,78 |
| EV/EBITDA | 10,15 | Dividend Yield | 0,03% |
| Market Cap | 6,16B | Enterprise Value | 6,74B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 6,60B | 7,38B | 7,09B | 5,21B | 3,19B |
| Net Income | 405,14M | 2,02B | 2,01B | 2,87B | 1,75B |
| EPS (Diluted) | 0,47 | 2,34 | 2,32 | 3,30 | 2,19 |
| Gross Profit | 2,24B | 2,85B | 2,81B | 2,27B | 1,51B |
| Operating Income | 664,42M | 2,49B | 2,58B | 1,92B | 1,12B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 28,67B | 29,68B | 27,45B | 23,74B | 19,51B |
| Total Liabilities | 4,61B | 5,23B | 4,77B | 3,14B | 1,65B |
| Shareholders' Equity | 20,67B | 21,03B | 19,58B | 18,12B | 16,12B |
| Total Debt | 2,63B | 2,83B | 2,80B | 1,19B | 384,94M |
| Cash & Equivalents | 2,06B | 7,42B | 7,86B | 8,54B | 10,12B |
| Current Assets | 6,30B | 11,34B | 11,11B | 10,85B | 11,65B |
| Current Liabilities | 3,66B | 4,14B | 3,73B | 2,41B | 1,14B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#401 of 820
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026